Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
On24
Virtual Event
mPower Conference Session: Auto Casualty Trends
On-Demand
Enlyte
Article
Release of Generic Medications for Workers' Comp in 2022
Next year twenty-eight drugs relevant to workers’ compensation are expected to become available as generics.
Nina Smith: Navigating Next – Lessons Learned from within a Workers’ Comp Consolidation
News Release
Nina Smith: Navigating Next – Lessons Learned from within a Workers’ Comp Consolidation
Nina Smith: Adaptability – Listening to Customers During COVID-19
News Release
Nina Smith: Adaptability – Listening to Customers During COVID-19
Workers' Comp
Article
Modifications to Living Spaces Make Injured Workers Feel at Home
Risk & Insurance
News Release